Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01031459 · ClinicalTrials.gov registry record

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

A clinical trial of Multiple Sclerosis, sponsored by Bayer.

Completed
Registry status
176
Enrollment target
10
Study locations

NCT01031459 is a study of Multiple Sclerosis that has completed, run by Bayer. The registered enrollment target is 176 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (70% lower). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01031459, a study of Multiple Sclerosis, has completed, sponsored by Bayer.

COMPLETED
Registry status
176 participants
Enrollment target
10
Study locations

Study Summary

The purpose of this study is to investigate the clinical status of patients who participated in the original pivotal Betaseron study at 20 years after randomized treatment initiationStudy end-points include: 1. Mortality - All-cause mortality - Cause specific mortality - Multiple sclerosis-related mortality 2. EDSS (Expanded Disability Status Scale) 3. Cognition 4. Resource use 5. SPMS (Secondary Progressive Multiple Sclerosis) status 6. Employment history

Conditions Studied

Multiple Sclerosis

Interventions

  • DRUG Betaseron (Interferon beta-1b, BAY86-5046)

Study Locations (10)

Quebec

  • - Montreal
  • - Montreal

Alabama

  • - Birmingham

Arizona

  • - Tucson

California

  • - San Francisco

Illinois

  • - Chicago

Maryland

  • - Baltimore

Pennsylvania

  • - Philadelphia

British Columbia

  • - Vancouver

Trial Details

FieldValue
Enrollment Target 176 participants
Start Date 2010-01
Est. Completion 2010-12

Sponsor

Bayer

591 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01031459

The ClinicalTrials.gov registry entry for NCT01031459 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (70% lower). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Betaseron (Interferon beta-1b, BAY86-5046) is the first listed.

NCT01031459 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Quebec, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT01031459 about?

NCT01031459 is a clinical study titled "Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.". The purpose of this study is to investigate the clinical status of patients who participated in the original pivotal Betaseron study at 20 years after randomized treatment initiationStudy end-points include: 1. Mortality - All-cause mortality - Cause specific mortality - Multiple sclerosis-related ...

What is the current status of trial NCT01031459?

This trial is currently completed. The enrollment target is 176 participants. The study started on 2010-01. Estimated completion is 2010-12.

What conditions does trial NCT01031459 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT01031459?

The interventions under investigation include: Betaseron (Interferon beta-1b, BAY86-5046) (DRUG).

Who is sponsoring clinical trial NCT01031459?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01031459 being conducted?

This trial has 10 study locations across Alabama, Arizona, California, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.